| Financial Year |
March 31 2023 |
| Monetary Funds |
10,164,102,788.11 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
170,407,270.16 |
| Advances to Suppliers |
85,351,531.96 |
| Other Receivables |
2,252,571.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
780,488,972.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,349,923.96 |
| Total Current Assets |
12,580,764,735.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
265,101,045.61 |
| Investment Properties |
7,505,596.28 |
| Fixed Assetes |
2,883,165,507.53 |
| Under-construction Projects |
26,621,940.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
318,446,847.47 |
| R&D expenses |
-- |
| Goodwill |
73,320,499.48 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
56,587,263.81 |
| Other Non-Current Assets |
16,526,280.00 |
| Sub-Total of Non-Current Assets |
3,647,481,646.51 |
| Total Assets |
16,228,246,382.09 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
245,864.07 |
| Notes Payable |
-- |
| Accounts Payable |
938,022,728.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,177,862.55 |
| Taxes Payable |
1,165,794,791.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,000,480.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
55,593,574.70 |
| Sub-Total of Current Liabilities |
2,672,101,818.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
16,569,705.18 |
| Deferred Income Tax Liabilities |
20,142,237.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
139,907,947.29 |
| Total Liabilities |
2,812,009,766.12 |
| Paid-In Capital(Or Share Stock) |
414,693,493.00 |
| Capital Surplus |
2,697,285,773.78 |
| Surplus Reserve |
442,279,068.54 |
| LESS:Treasury Stock |
22,685,300.00 |
| Undistributed Profits |
9,649,758,515.42 |
| Minority Stockholder's Interest |
205,241,387.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,210,995,228.65 |
| Owner's Equity（Stockholder's Equity） |
13,416,236,615.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,228,246,382.09 |
